N, S., S, S., M, R., & A, R. (2019). Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats. Dove Medical Press.
Style de citation Chicago (17e éd.)N, Samsu, Soeharto S, Rifai M, et Rudijanto A. Rosmarinic Acid Monotherapy Is Better than the Combination of Rosmarinic Acid and Telmisartan in Preventing Podocyte Detachment and Inhibiting the Progression of Diabetic Nephropathy in Rats. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)N, Samsu, et al. Rosmarinic Acid Monotherapy Is Better than the Combination of Rosmarinic Acid and Telmisartan in Preventing Podocyte Detachment and Inhibiting the Progression of Diabetic Nephropathy in Rats. Dove Medical Press, 2019.